Gleevec, the targeted cancer pill, delivers more good news to patients Gleevec, the targeted cancer pill that has saved more than 100,000 lives, now is saving more children with a dire leukemia, as well as preventing disease progression with long term use in adults with chronic myeloid leukemia.
Source: EurekAlert Posted on:
Monday, Dec 10, 2007, 9:49am Views: 1117